Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Real world drug utilization patterns in the first years following a relapsing-remitting multiple sclerosis diagnosis.
Herpes Simplex Virus Type 1 Infects Schwann Cells via Exosomal CD81, Exploits the MVB-Exosomal Pathway, and Induces Demyelination.
Seeing the unseen in multiple sclerosis: From reactive care to anticipatory medicine.
GLP-1 receptor agonists in multiple sclerosis: Weight loss without disease modification - Are we measuring the right outcomes?
Clinical features and treatment response of anti-Neurofascin 155 antibody-positive neuropathy in neurological Institute of Thailand.
Phenotyping healthcare use before pediatric-onset multiple sclerosis, including by sex and age: A matched cohort study.
Comparative impact of mental and cardiovascular comorbidities on adverse outcomes in people with MS.
Suspected HSV vs. demyelinating transverse myelitis in patient on TNF alpha inhibitor: a case report.
The role of health literacy in medication adherence among people living with multiple sclerosis: a cross-sectional study in Isfahan, Iran.
Sex-Related Differences in Circular RNA Expression in Multiple Sclerosis: A Pilot Study.
Case 346: γ-Aminobutyric Acid A Receptor Encephalitis.
Artificial Intelligence in Neuroradiology: A Review of FDA-regulated Algorithms.
Adverse Effects of Non-Medical Use of Cannabis or Opioids Associated with Adverse Childhood Experiences.
Serum Uric Acid Trajectories in Multiple Sclerosis: A 5-Year Longitudinal Comparison of High- and Moderate-Efficacy Therapies.
Real-world comparison of anti-CD20 therapies: efficacy, infections, and immune profiles in a German cohort.
Importance of physiotherapy and occupational therapy according to people with multiple sclerosis-results from an online survey.
Sphingosine-1-Phosphate Is a Key Signaling Molecule in Normal Conditions and in Multiple Sclerosis.
Novel mutation associated with transient hypomyelination of infancy - lessons from a previously negative whole-exome sequencing case: Three case reports.
Law's Praxis-On Becoming Self-Actualized.
Identifying Risk Factors for the Rising Prevalence of Multiple Sclerosis in Saudi Arabia: A case-control analysis.
Repeat radiofrequency thermocoagulation for multiple sclerosis-associated versus idiopathic trigeminal neuralgia: a comparison of long-term pain control.
Antinuclear antibodies, apoptotic factors sFas and sFasL, and chemokines CXCL8, CXCL10, and CCL20 as prognostic biomarkers in multiple sclerosis.
Molecular interplay between Non-coding RNAs and BDNF in Neurodegenerative Disorders: a systematic review.
Evaluation of a virtual reality-based perimetry device (RVF100) for visual field testing: a comparison with the Humphrey visual field analyzer.
Synergistic Interaction Between MALAT1/miR-30b-5p/BAFF Axis and Inflammatory Cytokines Underlies Rituximab-Refractory NMOSD.
Pages
« first
‹ previous
…
999
1000
1001
1002
1003
1004
1005
1006
1007
…
next ›
last »